Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-04-11 @ 7:56 AM
Study NCT ID:
NCT00617669
Status:
COMPLETED
Last Update Posted:
2012-09-10
First Post:
2008-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4320C00033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None